ロード中...
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
COVID-19 vaccination is recommended for multiple sclerosis patients. Disease-modifying therapies can influence the safety and efficacy of COVID-19 vaccines. RNA, DNA, protein, and inactivated vaccines are likely safe for multiple sclerosis patients. A few incidences of central demyelination were rep...
保存先:
| 出版年: | J Neuroimmunol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095041/ https://ncbi.nlm.nih.gov/pubmed/34000472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2021.577599 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|